No Data
No Data
MIRA Pharmaceuticals Announced A Key Development Milestone For Its Novel Topical Formulation Of Ketamir-2 Demonstrated Successful, Dose-proportional Drug Release In A Validated Laboratory Study-8K
Express News | Reported Earlier: 'Texas Lawmakers Take Up Bills To Expedite Access To Psychedelic Therapy' - Marijuana Moment
Is Mira Pharmaceuticals Gaining or Losing Market Support?
BriaCell Therapeutics BCTX Phase 2 Survivor Data; MIRA Pharmaceuticals MIRA Preclinical Ketamine
Sector Update: Health Care Stocks Slide Late Afternoon
Top Midday Gainers